Cleared Traditional

K990956 - BIOSENSOR HOLTER MONITOR SYSTEM SOFTWARE, MODEL 1005

K990956 is an FDA 510(k) clearance for BIOSENSOR HOLTER MONITOR SYSTEM SOFTWARE, manufactured by Biosensor Corp.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K990956 · Biosensor Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1999
Decision
84d
Days
Class 2
Risk

K990956 is an FDA 510(k) clearance for the BIOSENSOR HOLTER MONITOR SYSTEM SOFTWARE, MODEL 1005. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Biosensor Corp. (Burnsville, US). The FDA issued a Cleared decision on June 14, 1999 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Biosensor Corp. devices

FDA 510(k) Submission Details - K990956

510(k) Number K990956 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 22, 1999
Decision Date June 14, 1999
Days to Decision 84 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 125d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 305
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K990956.
MAC-LAB SYSTEM
K992948 · General Electric Medical Systems Information Techn · Nov 1999
SYNEFLASH & SYNEVIEW
K990727 · Ela Medical, Inc. · Nov 1999
CARTO EP NAVIGATION SYSTEM
K992968 · Biosense Webster, Inc. · Sep 1999
CARDIAC DIAGNOSTIC SYSTEM MODEL CH 2000
K983102 · Cambridge Heart, Inc. · Apr 1999
MT-200
K973751 · Schiller America, Inc. · Aug 1998
BIOSENSOR HOLTER MONITOR SYSTEM
K974192 · Biosensor Corp. · Mar 1998